Logo image of BMR

BEAMR IMAGING LTD (BMR) Stock Fundamental Analysis

NASDAQ:BMR - Nasdaq - IL0011832438 - Common Stock - Currency: USD

3.57  +0.14 (+4.08%)

Premarket: 3.61 +0.04 (+1.12%)

Fundamental Rating

3

Overall BMR gets a fundamental rating of 3 out of 10. We evaluated BMR against 282 industry peers in the Software industry. No worries on liquidiy or solvency for BMR as it has an excellent financial health rating, but there are worries on the profitability. BMR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BMR has reported negative net income.
In the past year BMR has reported a negative cash flow from operations.
In the past 5 years BMR always reported negative net income.
BMR had negative operating cash flow in 4 of the past 5 years.
BMR Yearly Net Income VS EBIT VS OCF VS FCFBMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -24.07%, BMR is not doing good in the industry: 70.57% of the companies in the same industry are doing better.
BMR's Return On Equity of -25.23% is on the low side compared to the rest of the industry. BMR is outperformed by 60.28% of its industry peers.
Industry RankSector Rank
ROA -24.07%
ROE -25.23%
ROIC N/A
ROA(3y)-13.88%
ROA(5y)-18.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMR Yearly ROA, ROE, ROICBMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

With an excellent Gross Margin value of 92.00%, BMR belongs to the best of the industry, outperforming 98.94% of the companies in the same industry.
In the last couple of years the Gross Margin of BMR has declined.
BMR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5YN/A
BMR Yearly Profit, Operating, Gross MarginsBMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

BMR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BMR has more shares outstanding
BMR has a better debt/assets ratio than last year.
BMR Yearly Shares OutstandingBMR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
BMR Yearly Total Debt VS Total AssetsBMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

BMR has an Altman-Z score of 30.82. This indicates that BMR is financially healthy and has little risk of bankruptcy at the moment.
BMR has a better Altman-Z score (30.82) than 95.74% of its industry peers.
There is no outstanding debt for BMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 30.82
ROIC/WACCN/A
WACC9.56%
BMR Yearly LT Debt VS Equity VS FCFBMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

BMR has a Current Ratio of 17.77. This indicates that BMR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 17.77, BMR belongs to the top of the industry, outperforming 97.52% of the companies in the same industry.
A Quick Ratio of 17.77 indicates that BMR has no problem at all paying its short term obligations.
BMR has a better Quick ratio (17.77) than 97.52% of its industry peers.
Industry RankSector Rank
Current Ratio 17.77
Quick Ratio 17.77
BMR Yearly Current Assets VS Current LiabilitesBMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BMR have decreased strongly by -143.60% in the last year.
BMR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.20%.
The Revenue has been decreasing by -2.44% on average over the past years.
EPS 1Y (TTM)-143.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-256.04%
Revenue 1Y (TTM)5.2%
Revenue growth 3Y-2.44%
Revenue growth 5YN/A
Sales Q2Q%5.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMR Yearly Revenue VS EstimatesBMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 1M 2M 3M
BMR Yearly EPS VS EstimatesBMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -0.05 -0.1 -0.15 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BMR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BMR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMR Price Earnings VS Forward Price EarningsBMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMR Per share dataBMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BMR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEAMR IMAGING LTD

NASDAQ:BMR (7/18/2025, 8:00:01 PM)

Premarket: 3.61 +0.04 (+1.12%)

3.57

+0.14 (+4.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.87%
Inst Owner Change0%
Ins Owners23.48%
Ins Owner Change0%
Market Cap55.41M
Analysts80
Price Target8.16 (128.57%)
Short Float %2.78%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.63
P/FCF N/A
P/OCF N/A
P/B 2.63
P/tB 3.42
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.26
BVpS1.36
TBVpS1.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.07%
ROE -25.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 92%
FCFM N/A
ROA(3y)-13.88%
ROA(5y)-18.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5YN/A
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 194.12%
Cap/Sales 8.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.77
Quick Ratio 17.77
Altman-Z 30.82
F-Score3
WACC9.56%
ROIC/WACCN/A
Cap/Depr(3y)314.52%
Cap/Depr(5y)189.33%
Cap/Sales(3y)5.82%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-143.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-256.04%
EPS Next Y-266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.2%
Revenue growth 3Y-2.44%
Revenue growth 5YN/A
Sales Q2Q%5.33%
Revenue Next Year5.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-153.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-160.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-186.19%
OCF growth 3YN/A
OCF growth 5YN/A